Once-Daily Indacaterol Acetate, Glycopyrronium Bromide, and Mometasone Furoate as a Fixed-Dose Combination in Japanese Patients with Inadequately Controlled Asthma: A Multicenter, 52-Week Safety Study

被引：0
|
作者：
Sagara, H. [1 ]
D'Andrea, P. [2 ]
Tanase, A. [3 ]
Pethe, A. [2 ]
Tanaka, Y. [4 ]
Matsuo, K. [4 ]
Hosoe, M. [3 ]
机构：
[1] Showa Univ, Sch Med, Dept Med, Div Allergol & Resp Med, Tokyo, Japan
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Novartis Pharma AG, Basel, Switzerland
[4] Novarts Pharma KK, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3012
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies
    Sagara, Hironori
    D'Andrea, Peter
    Tanase, Ana-Maria
    Pethe, Abhijit
    Tanaka, Yukina
    Matsuo, Kazutaka
    Hosoe, Motoi
    Nakamura, Yoichi
    JOURNAL OF ASTHMA, 2023, 60 (02) : 403 - 411
  • [2] Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma
    Buhl, Roland
    Nikolaev, Ivan
    Tillmann, Hanns-Christian
    Vaidya, Soniya
    Bartels, Christian
    Jain, Monish
    Jauernig, Juergen
    Kerstjens, Huib A. M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2021, 70
  • [3] Once-Daily Indacaterol Acetate and Mometasone Furoate Fixed-Dose Combination for Treatment of Inadequately-Controlled Asthma: Long-Term Safety Study in the Japanese Population
    Nakamura, Y.
    D'Andrea, P.
    Tanase, A.
    Pethe, A.
    Tanaka, Y.
    Matsuo, K.
    Hosoe, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/indacaterol/glycopyrronium in patients with asthma (vol 70, 102068, 2021)
    Buhl, Roland
    Nikolaev, Ivan
    Tillmann, Hanns-Christian
    Vaidya, Soniya
    Bartels, Christian
    Jain, Monish
    Jauernig, Juergen
    Kerstjens, Huib A. M.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 73
  • [5] Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials
    Scosyrev, Emil
    van Zyl-Smit, Richard
    Kerstjens, Huib
    Gessner, Christian
    Kornmann, Oliver
    Jain, Devendra
    Aubrun, Elodie
    D'Andrea, Peter
    Hosoe, Motoi
    Pethe, Abhijit
    Brittain, Dominic
    RESPIRATORY MEDICINE, 2021, 180
  • [6] Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once daily inhalation as a fixed-dose combination in healthy subjects
    Tillmann, Hanns-Christian
    Ethel, Brian
    Abdallah, Nasri
    Machineni, Surendra
    Drollmann, Anton
    Last, Stephanie
    Hahn, Michael
    Radhakrishnan, Rajkumar
    Ignatenko, Stanislav
    Vaidya, Soniya
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma
    Dominic Brittain
    Peter D’Andrea
    Emilie Gruen
    Motoi Hosoe
    Devendra Jain
    Juergen Jauernig
    Abhijit Pethe
    Emil Scosyrev
    Ana-Maria Tanase
    Hanns-Christian Tillmann
    Advances in Therapy, 2022, 39 : 2365 - 2378
  • [8] A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma
    Brittain, Dominic
    D'Andrea, Peter
    Gruen, Emilie
    Hosoe, Motoi
    Jain, Devendra
    Jauernig, Juergen
    Pethe, Abhijit
    Scosyrev, Emil
    Tanase, Ana-Maria
    Tillmann, Hanns-Christian
    ADVANCES IN THERAPY, 2022, 39 (06) : 2365 - 2378
  • [9] Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate as a fixed-dose combination in Japanese and Caucasian healthy subjects
    Tillmann, Hanns-Christian
    Inoue, Satoru
    Vaidya, Soniya
    Sakita, Yohei
    Machineni, Surendra
    Kobayashi, Kiyoshi
    Furihata, Kenichi
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [10] Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma
    Perez de Llano, Luis
    Naval, Elsa
    Mejia, Natalia
    Dominguez-Ortega, Javier
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (01) : 1 - 15
12345